Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 36: 903-905, 1990;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delahunty, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delahunty, T.

Clinical Chemistry, Vol 36, 903-905, Copyright © 1990 by American Association for Clinical Chemistry

Convenient screening for hemoglobin variants by using the Diamat HPLC system

T Delahunty
Laboratory Services, Division of Metpath Inc., San Jose, CA 95133.

Hemolysates from 102 different patients previously assessed for the presence of hemoglobin variants by cellulose acetate electrophoresis were reanalyzed with the Diamat, a microprocessor-controlled step- gradient HPLC technique designed to determine glycohemoglobin (Hgb A1c). This pool contained 81 abnormal specimens, each with one of seven different variant abnormalities. In all cases the HPLC technique correctly detected the presence or absence of a variant. The common S trait gave a large peak immediately after Hgb A, and the SS and SC variants gave clearly abnormal patterns, caused in part by the absence of Hgb A. The pattern from EE variants was distinguished by the appearance of the glycated fraction Hgb E1c, which is eluted at 4.7 instead of 4.2 min, whereas the AE pattern had two glycated peaks. Hemoglobins F, "fast", S, and C were discerned by the presence of a major peak at 3, 5.2, 6.5, and 7.5 min, respectively. The findings suggest that the Diamat is a convenient tool to detect and help diagnose variants in a screening pool.


The following articles in journals at HighWire Press have cited this article:


Home page
 J. Clin. Pathol.Home page
T Lahousen, R E Roller, R W Lipp, and W J Schnedl
Silent haemoglobin variants and determination of HbA1c with the HPLC Bio-Rad Variant II
J. Clin. Pathol., September 1, 2002; 55(9): 699 - 703.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
B. S. Szwergold, S. Howell, and P. J. Beisswenger
Human Fructosamine-3-Kinase: Purification, Sequencing, Substrate Specificity, and Evidence of Activity In Vivo
Diabetes, September 1, 2001; 50(9): 2139 - 2147.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
E K Cronin, C Normand, J S Henthorn, M Hickman, and S C Davies
Costing model for neonatal screening and diagnosis of haemoglobinopathies
Arch. Dis. Child. Fetal Neonatal Ed., November 1, 1998; 79(3): 161F - 167.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American Association for Clinical Chemistry.